KTTA

Pasithea Therapeutics Corp. - Common Stock (KTTA)

About Pasithea Therapeutics Corp. - Common Stock (KTTA)

Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.

Details

Daily high

$0.84

Daily low

$0.79

Price at open

$0.83

52 Week High

$2.06

52 Week Low

$0.28

Market cap

20.9M

Dividend yield

0.00%

Volume

187,717

Avg. volume

469,457

P/E ratio

-.24

Pasithea Therapeutics Corp. - Common Stock News